ArticleBritish journal of cancer2026
Deep learning-based prediction of lymph node metastasis and occult tumor cells in gastric cancer using histopathological images: a retrospective study.
Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymph node metastasis (LNM) is an important prognostic factor but is often underdiagnosed due to limitations in conventional assessment methods. We aimed to develop a deep learning (DL) model to predict LNM status from primary gastric cancer (GC) whole-slide images.
methodsThis retrospective study included 929 patients with GC from three independent cohorts across two centers. A DL model based on Clustering-constrained Attention Multiple Instance Learning was trained and validated to predict LNM from whole-slide images of primary tumors. The ability of the model to predict occult tumor cells (OTCs) in patients initially staged as pN0 and its prognostic value in patients with GC were examined.
resultsThe model demonstrated robust LNM predictive performance. Notably, it also predicted OTCs in patients initially staged as pN0. Patients staged as pN0 with OTCs had significantly worse survival outcomes than those staged as pN0 without OTCs (P = 0.003). The score generated by the model was an independent prognostic factor for patients with GC.
conclusionsOur DL-based model enables accurate prediction of LNM and OTCs from primary GC slides, serving as a valuable tool for guiding personalized clinical strategies and as a novel biomarker for prognostic evaluation in patients with GC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.